Skip to main content
Current Developments in Nutrition logoLink to Current Developments in Nutrition
. 2024 Feb 10;8(3):102103. doi: 10.1016/j.cdnut.2024.102103

Dietary Phytochemical Index in Relation to Metabolic Health Status, Serum Adropin, and Brain-Derived Neurotrophic Factor Levels in Adults

Shahnaz Amani Tirani 1,2, Keyhan Lotfi 3,4, Farnaz Shahdadian 1,5, Zahra Hajhashemy 1,2, Parisa Rouhani 6, Parvane Saneei 2,
PMCID: PMC10909649  PMID: 38440363

Abstract

Background

Little is known about the relationship between dietary intake of phytochemicals with metabolic health status and underlying mechanisms.

Objectives

Little is known about the relationship between dietary intake of phytochemicals with metabolic health status and underlying mechanisms. We hypothesized that dietary phytochemical index (DPI) improves metabolic health status by ameliorating serum concentrations of brain-derived neurotrophic factor (BDNF) and adropin.

Methods

A cross-sectional study was performed in 527 adults (286 males and 241 females). The dietary intakes of participants were collected by a 168-item food frequency questionnaire, and DPI was estimated as a percentage of energy intake derived from phytochemical-rich foods. Anthropometric variables, blood pressure, glycemic and lipid profiles, and biochemical variables were assessed. The metabolically unhealthy (MU) phenotype was determined based on the definition presented by Wildman et al.

Results

The MU phenotype was identified in 51.4% of male and 32.0% of female participants. Participants in the third tertile of DPI had 59% lower odds of MU than those in the first tertile (OR: 0.41; 95% CI: 0.19, 0.87) after considering potential confounders. Stratified analysis by sex and body mass index indicated that DPI was inversely related to MU phenotype in females (OR: 0.28; 95% CI: 0.08, 0.97) and normal-weight individuals (OR: 0.11; 95% CI: 0.02, 0.62). DPI was also inversely associated with hyperglycemia, hypertriglyceridemia, and chronic inflammation. Nonsignificant reduced odds of low BDNF (OR: 0.87; 95% CI: 0.42, 1.84) and adropin (OR: 0.75; 95% CI: 0.31, 1.79) were observed in individuals in the top tertile of DPI compared with those in the bottom tertile.

Conclusions

This study showed that individuals with higher dietary intake of phytochemicals had lower odds of MU, particularly females and normal-weight individuals. No significant relationship was observed between serum BDNF and adropin with phytochemical intake.

Keywords: metabolic health status, diet, dietary phytochemical index, brain-derived neurotrophic factor, adropin

Introduction

The global prevalence of obesity has increased significantly since 1980, such that approximately one-third of the world’s population suffers from obesity and overweight [1]. Obesity is known as a major risk factor for noncommunicable diseases (NCDs), including type 2 diabetes mellitus, fatty liver, hypertension, cardiovascular diseases, myocardial infarction, and stroke [2]. However, risk of NCDs does not drastically increase in a subgroup of obese people known as metabolically healthy obese (MHO) [3]. Previous studies have also demonstrated that normal-weight individuals with unfavorable metabolic health status, known as metabolically unhealthy (MU) normal-weight (MUNW), have higher risk of developing NCDs than metabolically healthy normal-weight (MHNW) individuals [4,5]. Therefore, metabolic health status could predict risk of future diseases better than obesity. The metabolic status is transient and the shifting condition from healthy to unhealthy is associated with an increased risk of NCDs [[6], [7], [8]]. Therefore, managing and maintaining metabolic health status throughout life via behavioral and medical strategies is of great importance.

Recent experimental and observational studies have discovered the metabolic role of some biomolecules, such as brain-derived neurotrophic factor (BDNF) and adropin. BDNF, a member of the nerve growth factor family, is mainly expressed in the central nervous system. This neurotrophic factor plays an important role in the growth, survival, and differentiation of neurons as well as synaptic plasticity [9,10]. Adropin, encoded by the energy homeostasis-associated gene (Enho), is a peptide hormone that is predominantly expressed in the liver but is also found in other body tissues such as the central nervous system, pancreas, kidney, heart, and small intestine [11]. The findings of previous studies have demonstrated that BDNF and adropin play their metabolic roles by affecting body energy homeostasis and glucose and fatty acids metabolism [12,13]. Reduced serum BDNF and adropin concentrations have also been observed in individuals with obesity or abnormal metabolic profiles [[14], [15], [16], [17]]. In addition, it seems that modifiable lifestyle factors such as dietary intake and physical activity can alter BDNF [[18], [19], [20]] and adropin [[21], [22], [23]] secretion.

Phytochemicals are bioactive substances in plant-based foods such as fruits, vegetables (except for potatoes), grains, and oilseeds, which have many health benefits [24,25]. The dietary phytochemical index (DPI), proposed recently by McCarty, is a simple and practical index for the assessment of total dietary phytochemical consumption. DPI is defined as the percent of energy intake derived from phytochemical-rich foods [26]. The association between DPI and metabolic syndrome (MetS) in Iranian adults was previously evaluated; higher adherence to DPI was associated with a reduced chance of MetS and some of its components, such as high blood pressure, central obesity, insulin resistance, and hypertriglyceridemia [[27], [28], [29]]. Additionally, a recent study in Switzerland reported that higher consumption of phytochemical-rich foods, indicated by higher DPI scores, has protective effects against cardiometabolic risk factors [30]. An inverse relationship was also reported between DPI and MU obesity (MUO) phenotype among 228 Iranian females with overweight or obesity [31]. A lower likelihood of MUO was also reported in adolescents with a higher intake of phytochemicals in a previous survey in Iran [32]. However, no prior study has investigated the relationship between DPI and metabolic health status, considering the possible role of BDNF and adropin. We postulated that DPI improves metabolic health status by ameliorating serum concentrations of BDNF and adropin. Thus, the present study examined the association between DPI and MU status, considering the probable role of BDNF and adropin.

Methods

Study design and participants

A cross-sectional study was undertaken among a somewhat representative sample of Iranian adults (aged 18–60 y) in 2021. The sample size of the present study was estimated based on a previous study that reported a prevalence of 49.4% for MU among Iranian adults [33]. The minimum required sample size was estimated to be 474, considering a power of 80%, type I error of 0.05, desired confidence interval (CI) of 0.95, and precision (d) of 4.5%. A stratified multistage cluster sampling approach was applied to select participants from 20 schools in 6 different educational districts (3–4 schools from each district) of Isfahan, a large central city of Iran. Participants from various socioeconomic classes were recruited from various job categories in randomly chosen schools, including teachers, administrative and managerial employees, assistants, and crews. Complete information on the subjects’ features, study design, and methodology was previously published [34]. Subjects were not included if they: 1) were following a special diet, 2) had a prior history of chronic diseases such as type 1 diabetes mellitus, cardiovascular diseases, stroke, and malignancy, or 3) were pregnant or lactating females. In total, 543 invited individuals agreed to participate in the present study (response rate = 90.5%), of which 16 people were excluded from the study for 1 of the following reasons: 1) left >70 items of the food frequency questionnaire (FFQ) blank (n = 4), 2) reported a total energy intake outside the range of 800–4200 kcal/d (n = 3), 3) had missing blood pressure values (n = 8), and 4) did not accept blood draw for biochemical analysis (n = 1). Finally, 527 individuals were included in the present analysis. All participants signed a written informed consent, and the study protocol was approved by the Ethics Committee of Isfahan University of Medical Sciences (no. 2401283).

Dietary assessment and DPI calculation

The usual dietary intake of participants was assessed by a validated Willet-format semiquantitative 168-item FFQ [35]. This questionnaire could provide reasonably valid measures for common dietary intakes of the Iranian adult population. The validation study of this FFQ demonstrated reasonable correlations between dietary intakes obtained from FFQ and those obtained from multiple 24-h dietary recalls (ranging from 0.11 to 0.60 in females and 0.24 to 0.71 in males). The reliability of this questionnaire was additionally evaluated by comparing nutrient intakes obtained from 2 FFQs administered 1 y apart. The mean energy-adjusted intraclass correlation coefficients were 0.59 and 0.60 for males and females, respectively [35]. The study participants were asked to report the frequency and amount of each consumed food item during the preceding year. Then, household measures were applied to convert portion sizes of consumed foods to grams per day [36]. Finally, daily intake of energy and all nutrients was obtained by Nutritionist IV software.

The following equation suggested by McCarty et al. [26] was applied to estimate DPI for each participant: DPI = [(dietary energy derived from phytochemical-rich foods (kcal)/total daily energy intake (kcal)) × 100]. Vegetables, fruits, natural vegetable and fruit juices, tomato sauces, whole grains, legumes, nuts, seeds, olives, and olive oil were considered as phytochemical-rich foods. Potato was not considered for DPI calculation, because of its limited content of phytochemicals.

Assessment of anthropometric indices and cardiometabolic risk factors: A trained dietitian measured anthropometric indices. All measurements were performed while individuals stood in light clothing and with no shoes. Weight (kg) was measured with a body composition analyzer (Tanita MC-780MA), and height (m) was measured to the nearest 0.1 cm using a tape measure. Waist circumference (cm) was measured to the nearest 0.1 cm at the end of a normal respiratory expiration by measuring halfway between the lower rib margin and iliac crest using a nonstretchable tape measure. The mean of 2 measurements of waist circumference was recorded. BMI (in kg/m2) was calculated by dividing weight by the height squared. Blood pressure was measured using a digital sphygmomanometer (OMRON, M3, HEM-7154-E) in the sitting position after a 5-min resting. For each subject, this measurement was repeated 2 times with a 5-min interval, and the mean of 2 measurements was used for the analyses.

Twelve-hour fasting venous blood samples were drawn to evaluate biochemical markers. Serum concentrations of fasting blood glucose (FBG), HDL cholesterol, and triglyceride (TG) were measured using an autoanalyzer (BioSystems). Moreover, serum concentrations of insulin (Monobined Inc.) and high-sensitivity C-reactive protein (hs-CRP) (turbidimetry kit, latex enhanced turbidimetric method) were assessed through commercial kits. Insulin resistance was evaluated based on the HOMA-IR by the use of the following formula: HOMA-IR = [(fasting insulin (mU/L) × FBG (mg/dL)]/405. The ELISA kits (Zellbio) were applied to measure serum concentrations of adropin and BDNF. The first decile of serum BDNF and adropin concentrations were considered as low serum BDNF and adropin values.

Defining metabolic health status

Participants were divided into 4 groups of metabolic health: MHNW, MHO/overweight (MHOW), MUNW, and MUO/overweight (MUOW), according to the method provided by Wildman et al. [37]. Based on this method, individuals with normal-weight (18.5 ≤ BMI < 25) and overweight or obesity (BMI ≥ 25) with ≥2 of the following risk factors were considered as MUNW and MUOW, respectively: 1) increased FBG (≥100 mg/dL), 2) decreased HDL cholesterol (<40 mg/dL in males and <50 mg/dL in females, 3) increased TGs (≥150 mg/dL), and 4) increased blood pressure (≥130/85 mmHg), 5) increased insulin resistance (HOMA-IR >90th percentile, or >3.99), 6) increased inflammatory protein hs-CRP (>90th percentile, or >6.14 mg/L). Individuals with normal-weight and overweight or obesity with <2 of the abovementioned risk factors were considered as MHNW and MHOW, respectively.

Assessment of other variables

A validated International Physical Activity Questionnaire-short form was applied to evaluate physical activity [38]. This questionnaire contains 7 questions reflecting the frequency (days per week) and duration (minutes per day) of walking, moderate intensity, and vigorous-intensity physical activities during the last week. Data from this tool was converted to metabolic equivalent minutes per week. Then, individuals were categorized into inactive, minimally active, or health-enhancing physical activity active.

The validated Persian version of the Hospital Anxiety and Depression Scale was used to assess depression among study participants [39]. This 14-item self-administered questionnaire encompasses 2 7-item subscales of anxiety and depression. Each item is scored on a 4-point Likert-type scale, and the final score of each subscale ranges from 0 to 21. Those with a final score of ≥8 were considered as having depression. Data regarding other covariates, including age, sex, smoking habits, marital and education status, and socioeconomic status, were collected by a self-reported questionnaire.

Statistical analyses

The normal distribution of quantitative data was assessed by the Kolmogorov-Smirnov test. Continuous and categorical variables were reported as mean ± SD or SE and percentages, respectively. Individuals were distributed in tertiles of DPI (T1: <25.27, T2: 25.27–36.44, and T3: >36.44). Then, continuous and categorical variables were compared across tertiles of DPI through the χ2 test and 1-way analysis of variance. To report adjusted dietary intakes of individuals across DPI tertiles, the analysis of covariance was used. Energy and macronutrients intakes were adjusted for age and sex, whereas intake of other nutrients was adjusted for energy intake, age, and sex. Binary logistic regression was applied to evaluate the association between DPI and MU and its components by reporting odds ratios (ORs) and 95% CIs in crude and multivariable adjusted models. Based on previous literature [27,30,40], in model 1, age, sex, and energy intake were controlled. Physical activity, smoking, marital status, educational status, and socioeconomic status were additionally adjusted in model 2. The effect of BMI was additionally adjusted in model 3. The first tertile of DPI was considered as the reference category. DPI tertiles were considered as continuous variables in logistic regression models to determine trends. Furthermore, stratified analyses were performed based on sex (males compared with females) and BMI categories (those with normal-weight compared with those with overweight or obesity). Crude and multivariable adjusted ORs and 95% CIs were also used to estimate the odds of low BDNF and adropin values in DPI tertiles. All statistical analyses were done by Statistical Package for Social Sciences version 20 (SPSS Inc.). P values of <0.05 were considered statistically significant.

Results

In total, 527 adults, comprising 286 males and 241 females with a mean age of 42.66±11.19 (SD) y and a mean BMI of 26.91± 4.43, were included in the present study. Among them, 42.5% (147 males and 77 females) had an MU phenotype. Among normal-weight individuals, 20.5% had an MU phenotype, whereas 79.5 % of subjects with overweight or obesity were MU.

General characteristics of the study population across tertiles of DPI are presented in Table 1. A significant difference was observed in mean age (P < 0.001), weight (P = 0.04), and high hs-CRP values (P = 0.01) among tertiles of DPI. Participants with the highest adherence to DPI were more likely to be females (P < 0.001), have higher socioeconomic status (P = 0.01), and university level education (P = 0.01). No significant differences were observed for other subjects’ characteristics across tertiles of DPI.

TABLE 1.

General characteristics and cardiometabolic factors of study participants across tertiles of dietary phytochemical index1

DPI tertiles
P value2
T1 (n = 175)
(<25.27)
T2 (n = 176)
(25.27, 36.44)
T3 (n = 176)
(>36.44)
Age (y) 39.73±11.52 41.42±9.69 46.80± 11.09 <0.001
Sex, % <0.001
 Males 65.1 55.1 42.6
 Females 34.9 44.9 57.4
Marital status, % 0.25
 Single 20.8 11.9 16.2
 Married 78.0 86.9 82.1
 Divorced or widow 1.2 1.1 1.7
Education status, % 0.01
 Diploma or lower 16.0 5.1 12.1
 Higher than diploma 84.0 94.9 87.9
Socioeconomic status 3, % 0.01
 Low 43.0 25.0 25.5
 Moderate 30.6 35.3 29.6
 High 26.4 39.7 44.9
Weight (kg) 76.55±15.01 77.25±14.40 73.53±14.15 0.04
BMI (kg/m2) 26.50±4.42 27.27±4.17 26.95±4.69 0.27
Waist circumference (cm) 92.39±12.16 93.60±10.86 91.99±11.42 0.39
BMI categories, % 0.06
 Normal-weight 38.9 27.3 30.7
 Overweight/obese 61.1 72.7 69.3
Smoking, % 0.54
 Nonsmoker 93.0 92.5 95.4
 Ex-smoker 2.5 3.8 3.3
 Current smoker 4.4 3.8 1.3
Physical activity levels, % 0.14
 Inactive 59.0 58.5 52.6
 Minimally active 30.1 35.8 40.6
 HEPA active 11.0 5.7 6.9
High systolic blood pressure (mmHg) 24.0 24.4 33.0 0.10
High diastolic blood pressure (mmHg) 39.4 40.9 39.2 0.94
High fasting blood glucose (mg/dL) 20.0 18.8 20.5 0.92
High triglycerides (mg/dL) 37.7 39.2 33.0 0.45
Low HDL cholesterol (mg/dL) 9.7 12.5 12.5 0.64
High hs-CRP (>90th percentile) 16.0 4.5 9.1 0.01
High HOMA-IR index (>90th percentile) 9.1 9.7 10.8 0.87

Abbreviations: ANOVA, analysis of variance; DPI, dietary phytochemical index; HEPA, health-enhancing physical activity; hs-CRP, high-sensitivity C-reactive protein.

1

Values are mean ± SD, unless indicated.

2

Obtained from 1-way ANOVA and χ2 test for quantitative and categorical variables, respectively.

3

Socioeconomic status score was evaluated based on the job, family size, having a car in the family, having a computer/laptop, and having travel by using a validated questionnaire.

Dietary intakes of the study population across tertiles of DPI are reported in Table 2. Individuals in the highest tertile of DPI had a higher intake of energy, carbohydrates, fruits, vegetables, nuts, fiber, vitamin A, vitamin K, vitamin C, vitamin B6, folate, magnesium, and fructose and consumed a lower amount of total fat, SFA, MUFA, and PUFA than those in the lowest tertile. No significant differences were observed in the consumption of protein, whole grains, cholesterol, vitamin E, thiamin, riboflavin, niacin, vitamin B12, and calcium among DPI tertiles.

TABLE 2.

Dietary intakes (energy, macro/micro nutrients, and food groups) of study participants across tertiles of dietary phytochemical index1

DPI tertiles
T1 (n = 175)
(<25.27)
T2 (n = 176)
(25.27, 36.44)
T3 (n = 176)
(>36.44)
P value2
Energy (kcal) 2164.34±52.19 2304.09±50.88 2361.85±52.85 0.03
Protein, % of energy 14.44±0.22 14.46±0.21 13.85±0.22 0.10
Carbohydrate, % of energy 58.89±0.61 59.99±0.60 63.83±0.62 <0.001
Fat, % of energy 27.90±0.51 27.43±0.50 25.09±0.52 <0.001
Cholesterol (mg) 286.13±9.06 281.23±8.80 260.49±9.16 0.12
SFA (g) 24.28 ±0.59 22.49±0.57 20.16±0.60 <0.001
MUFA (g) 23.10±0.52 22.01±0.50 20.18±0.52 0.01
PUFA (g) 16.29 ±0.56 17.09±0.55 14.73±0.57 0.01
Vitamin A, (RAE) 940.23 ±65.91 1235.32 ±63.99 1823.41±66.62 <0.001
Vitamin E (mg) 6.53±0.24 6.94±0.23 7.16±0.24 0.19
Vitamin K (Ug) 119.86±6.88 153.31±6.68 182.61±6.96 <0.001
Vitamin C (mg) 134.75±6.77 191.75±6.57 268.48±6.84 <0.001
Thiamin (mg) 2.05±0.32 2.03±0.31 2.04±0.32 0.90
Riboflavin (mg) 1.92±0.05 2.02±0.04 2.01±0.05 0.26
Niacin (mg) 23.61±0.35 22.88±0.34 22.37±0.36 0.06
Vitamin B6 (mg) 1.55±0.04 1.79±0.03 2.06±0.04 <0.001
Folate (μg) 282.02±8.02 347.47 ±7.78 395.75 ±8.10 <0.001
Vitamin B12 (μg) 4.25±0.14 4.28±0.13 3.84±0.14 0.05
Magnesium (mg) 252.22±4.79 290.04±4.65 309.15±4.85 <0.001
Calcium (mg) 892.65±28.92 957.29±28.08 921.96±29.23 0.27
Fructose (g) 15.60±0.84 19.79±0.81 27.89±0.85 <0.001
Total fiber (g) 16.03±0.39 20.90±0.37 26.54±0.39 <0.001
Fruits (g) 336.23±20.58 533.40±19.98 797.16±20.80 <0.001
Vegetables (g) 247.53±16.29 326.00±15.82 450.40±16.47 <0.001
Whole grains (g) 120.63±6.21 108.12±6.03 108.83±6.27 0.28
Legumes (g) 30.84±2.81 44.24±2.73 42.63±2.85 0.01
Nuts (g) 7.28±0.95 13.18±0.92 15.02± 0.96 <0.001

Abbreviations: ANCOVA, analysis of covariance; DPI, dietary phytochemical index, RAE, retinol activity equivalents.

1

Values are mean ± SE. Energy intake and macronutrients were adjusted for age and sex; all other values were adjusted for age, sex, and energy intake.

2

P value obtained from ANCOVA test for adjustment of energy intake.

The frequency of participants with an MU phenotype across DPI tertiles is presented in Figure 1. A MUNW phenotype was observed in 30.9%, 25.0%, and 24.1% of normal-weight individuals in tertiles 1, 2, and 3 of DPI (P = 0.65) (Figure 1A). In addition, 50.5%, 46.9%, and 52.5% of individuals with overweight or obesity were identified as MUOW in tertiles 1, 2, and 3 of DPI (P = 0.67) (Figure 1B).

FIGURE 1.

FIGURE 1

Prevalence of metabolically unhealthy phenotype in individuals with (A) normal-weight and (B) obesity or overweight in tertiles of dietary phytochemical index.

Multivariate adjusted ORs and 95% CI for MU status across tertiles of DPI are presented in Table 3. In the crude model, there was no significant association between DPI tertiles and MU status (OR: 1.04; 95% CI: 0.68, 1.58). However, the association became significant in model 2 after adjustment for confounders (including age, sex, energy intake, physical activity, smoking, marital, educational, and socioeconomic status) (OR: 0.47; 95% CI: 0.22, 0.98). In the fully adjusted model, participants in the highest tertile of DPI had 59% significantly lower odds of MU status than those in the lowest tertile (OR: 0.41; 95% CI: 0.19, 0.87). As shown in Table 3, stratified analysis by sex revealed no significant association between DPI categories and MU status among females in the crude model (OR: 0.92; 95% CI: 0.47, 1.81). Again, this relationship became significant in model 2, and after considering all potential cofounders, females in the third tertile of DPI had 72% significantly reduced odds for MU phenotype in comparison with those in the first tertile (OR: 0.28; 95% CI: 0.08, 0.97). No significant association was observed between DPI tertiles and MU status either in crude (OR: 1.58; 95% CI: 0.87, 2.84) or fully adjusted model (OR: 0.41; 95% CI: 0.13, 1.28) among males.

TABLE 3.

Multivariable adjusted odds ratio and 95% confidence interval for metabolically unhealthy status across tertiles of dietary phytochemical index1

DPI tertiles
T1 (<25.27) T2 (25.27, 36.44) T3 (>36.44) P-trend
All participants
 Cases/participants (n) 75/175 72/176 77/176
 Crude 1 0.92 (0.60, 1.41) 1.04 (0.68, 1.58) 0.87
 Model 12 1 0.85 (0.54, 1.33) 0.75 (0.46, 1.23) 0.25
 Model 23 1 0.69 (0.37, 1.30) 0.47 (0.22, 0.98) 0.04
 Model 34 1 0.56 (0.29, 1.08) 0.41 (0.19, 0.87) 0.02
Males
 Cases/participants (n) 54/114 49/97 44/75
 Crude 1 1.13 (0.66, 1.95) 1.58 (0.87, 2.84) 0.14
 Model 12 1 0.90 (0.50, 1.60) 0.87 (0.45, 1.69) 0.67
 Model 23 1 0.67 (0.30, 1.50) 0.55 (0.19, 1.61) 0.24
 Model 34 1 0.52 (0.22, 1.21) 0.41 (0.13, 1.28) 0.09
Females
 Cases/participants (n) 21/61 23/79 33/101
 Crude 1 0.78 (0.38, 1.60) 0.92 (0.47, 1.81) 0.89
 Model 12 1 0.78 (0.37, 1.64) 0.62 (0.30, 1.28) 0.20
 Model 23 1 0.67 (0.21, 2.13) 0.28 (0.08, 0.95) 0.04
 Model 34 1 0.59 (0.18, 1.93) 0.28 (0.08, 0.97) 0.04
1

All values are odds ratios and 95% confidence intervals.

2

Model 1: Adjusted for age, sex, and total energy intake. In stratified analysis by sex, adjusted for age and total energy intake.

3

Model 2: Additionally adjusted for physical activity, smoking, marital status, educational status, and socioeconomic status.

4

Model 3: Additionally adjusted for BMI.

Stratified analysis by BMI showed that in normal-weight participants, there was no significant association between DPI tertiles and MU status in the crude model (OR: 0.71; 95% CI: 0.32, 1.59) (Figure 2A). However, after making adjustments for confounders, participants in the highest tertile of DPI showed an 89% significant reduced odds for MU phenotype compared with those in the bottom tertile (OR: 0.11; 95% CI: 0.02, 0.62). No significant association was observed between DPI and MU phenotype either in crude (OR: 1.08; 95% CI: 0.64, 1.82) or fully adjusted model (OR: 0.62; 95% CI: 0.24, 1.61) among individuals with overweight or obesity (Figure 2B).

FIGURE 2.

FIGURE 2

Multivariate adjusted odds ratio and 95% confidence intervals (CIs) for the metabolically unhealthy phenotype in individuals with (A) normal-weight and (B) obesity or overweight. Model 1: adjusted for age, sex, and total energy intake; Model 2: further adjustment for physical activity, smoking, marital status, educational status, and socioeconomic status. DPI, dietary phytochemical index.

Multivariate adjusted ORs and 95% CIs for components of metabolic health status across tertiles of DPI are presented in Table 4. No significant association was found between DPI and components of metabolic health in the crude model. However, after controlling for confounders, participants in the third tertile of DPI showed significantly decreased odds of high FBG (OR: 0.40; 95% CI: 0.17, 0.96), high TG (OR: 0.42; 95% CI: 0.20, 0.88), and high hs-CRP (OR: 0.24; 95% CI: 0.08, 0.72) compared with the first tertile.

TABLE 4.

Multivariable adjusted odds ratio and 95% confidence interval for metabolic components across tertiles of dietary phytochemical index1

DPI tertiles
T1 (<25.27) T2 (25.27, 36.44) T3 (>36.44) P-trend
High blood pressure
 Crude 1 1.04 (0.68, 1.58) 1.16 (0.76, 1.77) 0.49
 Fully adjusted model2 1 0.63 (0.32, 1.25) 0.65 (0.30, 1.41) 0.25
High fasting blood glucose
 Crude 1 0.92 (0.54, 1.57) 1.03 (0.61, 1.73) 0.91
 Fully adjusted  model2 1 0.53 (0.24, 1.16) 0.40 (0.17, 0.96) 0.04
High triglyceride
 Crude 1 1.07 (0.69, 1.64) 0.81 (0.52, 1.26) 0.35
 Fully adjusted model2 1 0.68 (0.37, 1.26) 0.42 (0.20, 0.88) 0.02
Low HDL cholesterol
 Crude 1 1.33 (0.68, 2.60) 1.33 (0.68, 2.60) 0.42
 Fully adjusted model2 1 1.24 (0.48, 3.21) 1.07 (0.37, 3.09) 0.91
High HOMA-IR
 Crude 1 1.06 (0.52, 2.18) 1.20 (0.60, 2.42) 0.60
 Fully adjusted model2 1 1.32 (0.52, 3.35) 0.83 (0.29, 2.43) 0.76
High hs-CRP
 Crude 1 0.25 (0.11, 0.57) 0.53 (0.27, 1.01) 0.03
 Fully adjusted model2 1 0.20 (0.07, 0.59) 0.24 (0.08, 0.72) 0.01

Abbreviation: hs-CRP, high-sensitivity C-reactive protein.

1

All values are odds ratios and 95% confidence intervals.

2

Fully adjusted model: Adjusted for age, sex, total energy intake, physical activity, smoking, marital status, educational status, socioeconomic status, and BMI.

The mean values of serum BDNF and adropin across different metabolic health phenotypes are depicted in Figure 3. Participants with an MHOW phenotype had the lowest serum BDNF values [1.12±0.04 (SE) ng/mL], and those with an MUNW phenotype had the highest serum BDNF concentration [1.79 ±0.61 (SE) ng/mL] (P = 0.05). Furthermore, MUOW individuals showed the lowest serum adropin concentration [54.91±2.50 (SE) pg/mL], whereas the highest serum adropin concentrations were observed in MHNW individuals [59.39±4.36 (SE) pg/mL] (P = 0.79).

FIGURE 3.

FIGURE 3

Mean serum concentrations of (A) brain-derived neurotrophic factor and (B) adropin across categories of metabolic health status. BDNF, brain-derived neurotrophic factor; MHNW, metabolically healthy normal-weight; MHOW, metabolically healthy obese/overweight; MUNW, metabolically unhealthy normal-weight; MUOW, metabolically unhealthy obese/overweight.

Multivariate adjusted ORs and 95% CIs for low BDNF and adropin values (the first decile) across tertiles of DPI are presented in Table 5. In a fully adjusted model, 13% and 25% nonsignificant reduced odds for low BDNF and low adropin values were observed in individuals in the top tertile of DPI compared with those in the bottom tertile [(OR: 0.87; 95% CI: 0.42, 1.84); and (OR: 0.75; 95% CI: 0.31, 1.79), respectively].

TABLE 5.

Multivariable adjusted odds ratio and 95% confidence interval for low brain-derived neurotrophic factor and adropin values across tertiles of dietary phytochemical index1

DPI tertiles
T1 (<25.27) T2 (25.27, 36.44) T3 (>36.44) P-trend
Low BDNF
 Crude 1 0.83 (0.42, 1.64) 0.83 (0.42, 1.64) 0.59
 Model 12 1 0.81 (0.41, 1.62) 0.81 (0.39, 1.69) 0.57
 Model 23 1 0.85 (0.42, 1.71) 0.87 (0.42, 1.84) 0.66
Low adropin
 Crude 1 0.61 (0.28, 1.35) 1.00 (0.49, 2.03) 0.49
 Model 14 1 0.59 (0.26, 1.31) 0.90 (0.41, 1.94) 0.47
 Model 25 1 0.66 (0.29, 1.49) 0.74 (0.31, 1.76) 0.77
 Model 36 1 0.70 (0.30, 1.59) 0.75 (0.31, 1.79) 0.99

Abbreviation: BDNF, brain-derived neurotrophic factor.

1

All values are odds ratios and 95% confidence intervals.

2

Model 1: Adjusted for age and sex.

3

Model 2: Additionally adjusted for physical activity, depression, hypertension, history of diabetes mellitus, and hyperlipidemia.

4

Model 1: Adjusted for age, sex, and total energy intake.

5

Model 2: Additionally adjusted for physical activity and smoking.

6

Model 3: Additionally adjusted for BMI.

Discussion

The results of this cross-sectional study showed that the prevalence of MU status was >40% among Iranian adults. This prevalence was significantly higher among individuals with overweight or obesity than those with normal-weight (79.5 compared with 20.5%). Higher adherence to DPI was significantly related to a reduced chance of MU phenotype, particularly in females and normal-weight individuals. Investigating the relationship between DPI and components of metabolic health status has additionally shown that higher dietary phytochemical consumption was associated with lower odds of hyperglycemia, hypertriglyceridemia, and chronic inflammation. Furthermore, a nonsignificant inverse association was found between DPI with low BDNF and low adropin values.

NCDs are the leading causes of premature death and disability all around the globe, especially in developing countries where 80% of NCDs-related mortalities occur [41]. Metabolic and lifestyle risk factors are the most common causes of NCDs. Previous studies have shown that the prevalence of some NCDs, such as cardiovascular disease and chronic kidney disease, is higher in individuals with MUOW and MUNW phenotypes than in MHNW individuals [7,42]. Therefore, preventing shifting from a metabolically healthy status to MU status by dietary and lifestyle modifications can be beneficial in reducing the incidence of NCDs and correlated complications. Our results indicated that a higher dietary intake of phytochemical-rich foods such as fruits, vegetables, and nuts could be a beneficial approach to decrease the chance of MU, particularly in females and the normal-weight population. Therefore, the consumption of phytochemical-rich foods should be monitored in clinical settings; in case of insufficient consumption, relevant dietary education programs can be provided.

Although the beneficial role of phytochemicals on health has been indicated by various studies, few studies have investigated the relationship between dietary intake of these bioactive compounds and metabolic health status. DPI is an appropriate and simple tool to evaluate the intake of dietary phytochemicals and to investigate their effects on health in epidemiologic studies. The association between DPI and MetS and its components (such as hypertension, insulin resistance, and lipid profile disorders) has been investigated in previous research. Tehran Lipid and Glucose study [28] involving 2567 adult subjects reported that individuals in the highest DPI category showed reduced odds of hypertriglyceridemia and central obesity. However, no significant association was observed between DPI and other cardiometabolic risk factors [28]. The results of a prospective study in 1546 nonhypertensive Iranian adults indicated that higher adherence to DPI was associated with 48% reduced risk of incidence of hypertension [43]. Furthermore, the Korean National Health and Nutrition Examination survey involving 38,198 Koreans (≥30 y) reported an inverse association between DPI and hypertension prevalence [44]. In a longitudinal study, participants in the highest quartile of DPI had 86% reduced risk of incidence of hyperinsulinemia after 3 y of follow-up. The mentioned study has also indicated significant inverse relations between insulin resistance, insulin insensitivity, and DPI [29]. There were controversial findings regarding the association between DPI and lipid profiles. In a longitudinal study of 1983 adult subjects, significant inverse associations were found between DPI with total cholesterol, TG, and non-HDL cholesterol in males [45]. Another study in 235 patients with type 2 diabetes mellitus reported a significant positive association between DPI and HDL cholesterol; however, no significant association was observed between DPI with other lipid values [46]. To our knowledge, our study was among the first investigations that assessed the relationship between DPI and metabolic health status in Iranian adults. Similar to our results, Pourreza et al. [31] indicated that higher adherence to DPI was associated with a lower risk of MUOW phenotype in middle-aged females with overweight or obesity [31]. However, they have not assessed this linkage among males and normal-weight subjects. The mentioned study showed a significant relationship between DPI and HOMA-IR but not with other components of metabolic health status [31]. The differences in the findings of the abovementioned studies are probably because of different study designs and populations.

Decreased concentrations of BDNF and adropin among individuals with metabolic disorders such as obesity and diabetes mellitus might be associated with the regulatory role of these molecules on the metabolism of macronutrients [47,48]. Limited evidence from interventional studies documented the effect of diet on the serum concentration of these biomarkers in humans [18,22,23,49]. In the present study, we evaluated for the first time the relationship between DPI with low serum concentrations of BDNF and adropin to figure out whether these biomarkers facilitate the favorable role of phytochemical-rich foods on metabolic health status. Our study showed that higher adherence to DPI might reduce the odds of low serum concentration of BDNF and adropin; however, the association was not statistically significant. Further large-scale prospective surveys are warranted to discover the effect of dietary phytochemicals on serum concentrations of BDNF and adropin and underlying mechanisms in human subjects.

The exact mechanisms explaining the relationship between DPI and metabolic health status are not well understood; however, some mechanisms are proposed. Oxidative stress and inflammation can be determinant factors in the etiology of MU phenotype [50,51]. Higher intake of phytochemical-rich foods may have favorable influences on metabolic health status through decreasing oxidative stress and inflammation. There is clear evidence about the effects of dietary phytochemicals such as phenolic acids, flavonoids, and carotenoids on reducing risk of cardiometabolic disorders through their antioxidant activity [24]. A growing body of in vitro and in vivo studies have suggested anti-inflammatory roles for phytochemicals from plant foods [52,53]; such that similar to our findings, a study in 18,699 Korean adults indicates an inverse trend between consumption of phytochemical-rich foods and inflammatory biomarkers such as high hs-CRP and white blood cell count [54].

The present study has several limitations that should be considered. First, it was not possible to establish a causal relationship between DPI and MU status, because of the cross-sectional design of the study. It should be considered that observed associations might be biased by reverse causation because individuals with cardiometabolic disorders might change their lifestyle behaviors. Thus, to explore a causal link between intake of phytochemicals and metabolic health status, well-designed prospective studies are needed. Second, although a validated FFQ has been used to collect usual dietary intakes, self-reported dietary intakes might be biased to recall bias and misclassification. Third, several confounders were taken into account; however, the confounding role of some other confounders (such as muscle mass, sleep, and stress) on relationships remained to be considered. Fourth, the phytochemical content of food items with no calories, such as nonalcoholic beverages like tea and spices, or the bioavailability of phytochemicals, have been not considered in DPI estimation, which might affect the results. Fifth, there was no biomarker-based evidence for validation of DPI obtained from the applied FFQ; however, a number of previous studies reported the association between this index and chronic diseases [[55], [56], [57], [58]]. Finally, although the sample examined in this study (in terms of general characteristics such as socioeconomic status, smoking, marital status, and physical activity) was similar to a previous large-scale survey conducted in Isfahan [59], a relatively small sample of adults was studied. Thus, extrapolation of these findings to the general adult population should be done with caution. The applied definition of metabolic health status (Wildman et al. [37] method) included hs-CRP as an inflammatory index besides insulin resistance and other traditional cardiometabolic risk factors. Finally, the evaluation of adropin and BDNF as biomarkers with limited dietary information in epidemiologic studies was the other strength of the study.

In conclusion, we found an inverse association between DPI and MU phenotype, particularly among females and normal-weight individuals. DPI was inversely associated with hyperglycemia, hypertriglyceridemia, and chronic inflammation. However, no significant association was found between serum concentrations of BDNF and adropin with phytochemical intake. Further prospective research in various populations is required to confirm these findings.

Acknowledgments

None.

Author contributions

The authors’ responsibilities were as follows – SAT, KL, FS, ZH, PR, PS: contributed to the conception, design, data collection, data interpretation, manuscript drafting, and approval of the final version of the manuscript and agreed to all aspects of the work; and all authors: read and approved the final manuscript.

Conflict of interest

The authors report no conflicts of interest.

Funding

This work was supported by the Nutrition and Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran (no. 2401283) for conception, design, data analysis, and manuscript drafting.

Data availability

The data that support the findings of the present study are available from the corresponding author upon request.

References

  • 1.Chooi Y.C., Ding C., Magkos F. The epidemiology of obesity. Metabolism. 2019;92:6–10. doi: 10.1016/j.metabol.2018.09.005. [DOI] [PubMed] [Google Scholar]
  • 2.Blüher M. Obesity: global epidemiology and pathogenesis. Nat. Rev. Endocrinol. 2019;15(5):288–298. doi: 10.1038/s41574-019-0176-8. [DOI] [PubMed] [Google Scholar]
  • 3.Stefan N., Häring H.U., Hu F.B., Schulze M.B. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013;1(2):152–162. doi: 10.1016/S2213-8587(13)70062-7. [DOI] [PubMed] [Google Scholar]
  • 4.Stefan N., Schick F., Häring H.U. Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans. Cell Metab. 2017;26(2):292–300. doi: 10.1016/j.cmet.2017.07.008. [DOI] [PubMed] [Google Scholar]
  • 5.Rubin R. What’s the best way to treat normal-weight people with metabolic abnormalities? JAMA. 2018;320(3):223–225. doi: 10.1001/jama.2018.8188. [DOI] [PubMed] [Google Scholar]
  • 6.Søndergaard M.M., Hlatky M.A., Stefanick M.L., Vittinghoff E., Nah G., Allison M., et al. Association of adverse pregnancy outcomes with risk of atherosclerotic cardiovascular disease in postmenopausal women. JAMA Cardiol. 2020;5(12):1390–1398. doi: 10.1001/jamacardio.2020.4097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Eckel N., Li Y., Kuxhaus O., Stefan N., Hu F.B., Schulze M.B. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses’ Health Study): 30 year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol. 2018;6(9):714–724. doi: 10.1016/S2213-8587(18)30137-2. [DOI] [PubMed] [Google Scholar]
  • 8.Schulze M.B. Metabolic health in normal-weight and obese individuals. Diabetologia. 2019;62(4):558–566. doi: 10.1007/s00125-018-4787-8. [DOI] [PubMed] [Google Scholar]
  • 9.Yoshii A., Constantine-Paton M. Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease. Dev. Neurobiol. 2010;70(5):304–322. doi: 10.1002/dneu.20765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Cowansage K.K., LeDoux J.E., Monfils M.H. Brain-derived neurotrophic factor: a dynamic gatekeeper of neural plasticity. Curr. Mol. Pharmacol. 2010;3(1):12–29. doi: 10.2174/1874467211003010012. [DOI] [PubMed] [Google Scholar]
  • 11.Kumar K.G., Trevaskis J.L., Lam D.D., Sutton G.M., Koza R.A., Chouljenko V.N., et al. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell. Metab. 2008;8(6):468–481. doi: 10.1016/j.cmet.2008.10.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Podyma B., Parekh K., Güler A.D., Deppmann C.D. Metabolic homeostasis via BDNF and its receptors. Trends. Endocrinol. Metab. 2021;32(7):488–499. doi: 10.1016/j.tem.2021.04.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Kolben Y., Weksler-Zangen S., Ilan Y. Adropin as a potential mediator of the metabolic system-autonomic nervous system-chronobiology axis: implementing a personalized signature-based platform for chronotherapy. Obes. Rev. 2021;22(2) doi: 10.1111/obr.13108. [DOI] [PubMed] [Google Scholar]
  • 14.Lommatzsch M., Zingler D., Schuhbaeck K., Schloetcke K., Zingler C., Schuff-Werner P., et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol. Aging. 2005;26(1):115–123. doi: 10.1016/j.neurobiolaging.2004.03.002. [DOI] [PubMed] [Google Scholar]
  • 15.Bulló M., Peeraully M.R., Trayhurn P., Folch J., Salas-Salvadó J. Circulating nerve growth factor levels in relation to obesity and the metabolic syndrome in women. Eur. J Endocrinol. 2007;157(3):303–310. doi: 10.1530/EJE-06-0716. [DOI] [PubMed] [Google Scholar]
  • 16.Yosaee S., Khodadost M., Esteghamati A., Speakman J.R., Shidfar F., Nazari M.N., et al. Metabolic syndrome patients have lower levels of adropin when compared with healthy overweight/obese and lean subjects. Am. J Mens. Health. 2017;11(2):426–434. doi: 10.1177/1557988316664074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Butler A.A., Tam C.S., Stanhope K.L., Wolfe B.M., Ali M.R., O’Keeffe M., et al. Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans. J Clin. Endocrinol. Metab. 2012;97(10):3783–3791. doi: 10.1210/jc.2012-2194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Sánchez-Villegas A., Galbete C., Martinez-González M.A., Martinez J.A., Razquin C., Salas-Salvadó J., et al. The effect of the Mediterranean diet on plasma brain-derived neurotrophic factor (BDNF) levels: the PREDIMED-Navarra randomized trial. Nutr. Neurosci. 2011;14(5):195–201. doi: 10.1179/1476830511Y.0000000011. [DOI] [PubMed] [Google Scholar]
  • 19.Sleiman S.F., Henry J., Al-Haddad R., El Hayek L., Abou Haidar E., Stringer T., et al. Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrate. eLife. 2016;5 doi: 10.7554/eLife.15092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Molteni R., Barnard R.J., Ying Z., Roberts C.K., Gómez-Pinilla F. A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience. 2002;112(4):803–814. doi: 10.1016/s0306-4522(02)00123-9. [DOI] [PubMed] [Google Scholar]
  • 21.Fujie S., Hasegawa N., Sato K., Fujita S., Sanada K., Hamaoka T., et al. Aerobic exercise training-induced changes in serum adropin level are associated with reduced arterial stiffness in middle-aged and older adults. Am. J Physiol. Heart Circ. Physiol. 2015;309(10):H1642–H1647. doi: 10.1152/ajpheart.00338.2015. [DOI] [PubMed] [Google Scholar]
  • 22.Stevens J.R., Kearney M.L., St-Onge M.P., Stanhope K.L., Havel P.J., Kanaley J.A., et al. Inverse association between carbohydrate consumption and plasma adropin concentrations in humans. Obesity (Silver Spring) 2016;24(8):1731–1740. doi: 10.1002/oby.21557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.St-Onge M.P., Shechter A., Shlisky J., Tam C.S., Gao S., Ravussin E., et al. Fasting plasma adropin concentrations correlate with fat consumption in human females. Obesity (Silver Spring). 2014;22(4):1056–1063. doi: 10.1002/oby.20631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Guan R., Van Le Q., Yang H., Zhang D., Gu H., Yang Y., et al. A review of dietary phytochemicals and their relation to oxidative stress and human diseases. Chemosphere. 2021;271 doi: 10.1016/j.chemosphere.2020.129499. [DOI] [PubMed] [Google Scholar]
  • 25.Leitzmann C. Characteristics and health benefits of phytochemicals. Forsch. Komplementmed. 2016;23(2):69–74. doi: 10.1159/000444063. [DOI] [PubMed] [Google Scholar]
  • 26.McCarty M.F. Proposal for a dietary “phytochemical index,”. Med. Hypotheses. 2004;63(5):813–817. doi: 10.1016/j.mehy.2002.11.004. [DOI] [PubMed] [Google Scholar]
  • 27.Vasmehjani A.A., Darabi Z., Nadjarzadeh A., Mirzaei M., Hosseinzadeh M. The relation between dietary phytochemical index and metabolic syndrome and its components in a large sample of Iranian adults: a population-based study. BMC Public Health. 2021;21(1):1587. doi: 10.1186/s12889-021-11590-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Bahadoran Z., Golzarand M., Mirmiran P., Saadati N., Azizi F. The association of dietary phytochemical index and cardiometabolic risk factors in adults: Tehran Lipid and glucose Study. J Hum. Nutr. Diet. 2013;26(Suppl 1):145–153. doi: 10.1111/jhn.12048. [DOI] [PubMed] [Google Scholar]
  • 29.Bahadoran Z., Mirmiran P., Tohidi M., Azizi F. Dietary phytochemical index and the risk of insulin resistance and β-cell dysfunction: a prospective approach in Tehran lipid and glucose study. Int. J. Food Sci. Nutr. 2015;66(8):950–955. doi: 10.3109/09637486.2015.1111867. [DOI] [PubMed] [Google Scholar]
  • 30.Gamba M., Roa-Diaz Z.M., Raguindin P.F., Glisic M., Bano A., Muka T., et al. Association between dietary phytochemical index, cardiometabolic risk factors and metabolic syndrome in Switzerland. The CoLaus study. Nutr. Metab. Cardiovasc. Dis. 2023;33(11):2220–2232. doi: 10.1016/j.numecd.2023.07.018. [DOI] [PubMed] [Google Scholar]
  • 31.Pourreza S., Mirzababaei A., Naeini F., Naghshi S., Mirzaei K. Association of dietary phytochemical index with metabolically unhealthy overweight/obesity phenotype among Iranian women: A cross-sectional study. Front. Nutr. 2022;9 doi: 10.3389/fnut.2022.959341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Tirani S.A., Lotfi K., Mirzaei S., Asadi A., Akhlaghi M., Saneei P. The relation between dietary phytochemical index and metabolic health status in overweight and obese adolescents. Sci. Rep. 2023;13(1) doi: 10.1038/s41598-023-39314-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Rahmanian K., Shojaei M., Sotoodeh Jahromi A. Prevalence and clinical characteristics of metabolically unhealthy obesity in an Iranian adult population. Diabetes. Metab. Syndr. Obes. 2019;12:1387–1395. doi: 10.2147/DMSO.S197476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Poursalehi D., Shahdadian F., Hajhashemy Z., Lotfi K., Moradmand Z., Rouhani P., et al. Diet in relation to Metabolic, sleep and psychological health Status (DiMetS): protocol for a cross-sectional study. BMJ Open. 2023;13(12) doi: 10.1136/bmjopen-2023-076114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Mirmiran P., Esfahani F.H., Mehrabi Y., Hedayati M., Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13(5):654–662. doi: 10.1017/S1368980009991698. [DOI] [PubMed] [Google Scholar]
  • 36.Ghaffarpour M., Houshiar-Rad A., Kianfar H. The manual for household measures, cooking yields factors and edible portion of foods. Tehran: Nashre Olume Keshavarzy. 1999;7(213):42–58. [Google Scholar]
  • 37.Wildman R.P., Muntner P., Reynolds K., McGinn A.P., Rajpathak S., Wylie-Rosett J., et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004) Arch. Intern. Med. 2008;168(15):1617–1624. doi: 10.1001/archinte.168.15.1617. [DOI] [PubMed] [Google Scholar]
  • 38.Moghaddam M.B., Aghdam F.B., Jafarabadi M.A., Allahverdipour H., Nikookheslat S.D., Safarpour S. The Iranian version of International Physical Activity Questionnaire (IPAQ) in Iran: content and construct validity, factor structure, internal consistency and stability. World Appl. Sci. J. 2012;18(8):1073–1080. [Google Scholar]
  • 39.Montazeri A., Vahdaninia M., Ebrahimi M., Jarvandi S. The Hospital Anxiety and Depression Scale (HADS): translation and validation study of the Iranian version. Health Qual. Life Outcomes. 2003;1(1):14. doi: 10.1186/1477-7525-1-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Zujko M.E., Waśkiewicz A., Witkowska A.M., Szcześniewska D., Zdrojewski T., Kozakiewicz K., et al. Dietary total antioxidant capacity and dietary polyphenol intake and prevalence of metabolic syndrome in Polish adults: A nationwide study. Oxid. Med. Cell. Longev. 2018;2018 doi: 10.1155/2018/7487816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.World Health Organization . 2018. Noncommunicable diseases country profiles. 2018. [Google Scholar]
  • 42.Jam S.A., Moloudpour B., Najafi F., Darbandi M., Pasdar Y. Metabolic obesity phenotypes and chronic kidney disease: A cross-sectional study from the RaNCD cohort study. BMC Nephrol. 2022;23(1):233. doi: 10.1186/s12882-022-02858-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Golzarand M., Bahadoran Z., Mirmiran P., Sadeghian-Sharif S., Azizi F. Dietary phytochemical index is inversely associated with the occurrence of hypertension in adults: a 3-year follow-up (the Tehran Lipid and glucose Study) Eur. J. Clin. Nutr. 2015;69(3):392–398. doi: 10.1038/ejcn.2014.233. [DOI] [PubMed] [Google Scholar]
  • 44.Jo U., Park K. Phytochemical index and hypertension in Korean adults using data from the Korea National Health and Nutrition Examination Survey in 2008-2019. Eur. J. Clin. Nutr. 2022;76(11):1594–1599. doi: 10.1038/s41430-022-01155-w. [DOI] [PubMed] [Google Scholar]
  • 45.Golzarand M., Mirmiran P., Bahadoran Z., Alamdari S., Azizi F. Dietary phytochemical index and subsequent changes of lipid profile: A 3-year follow-up in Tehran Lipid and glucose Study in Iran. ARYA Atheroscler. 2014;10(4):203–210. [PMC free article] [PubMed] [Google Scholar]
  • 46.Abbasalizad Farhangi M., Najafi M. Empirically developed dietary inflammatory potential (EDIP) in patients candidate for coronary artery bypass grafting surgery (CABG): association with metabolic parameters, dietary antioxidant quality score and dietary phytochemical index. PLoS ONE. 2018;13(12) doi: 10.1371/journal.pone.0208711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Li B., Lang N., Cheng Z.F. Serum levels of brain-derived neurotrophic factor are associated with diabetes risk, complications, and obesity: a cohort study from Chinese patients with type 2 diabetes. Mol. Neurobiol. 2016;53(8):5492–5499. doi: 10.1007/s12035-015-9461-2. [DOI] [PubMed] [Google Scholar]
  • 48.Zang H., Jiang F., Cheng X., Xu H., Hu X. Serum adropin levels are decreased in Chinese type 2 diabetic patients and negatively correlated with body mass index. Endocr. J. 2018;65(7):685–691. doi: 10.1507/endocrj.EJ18-0060. [DOI] [PubMed] [Google Scholar]
  • 49.Gyorkos A., Baker M.H., Miutz L.N., Lown D.A., Jones M.A., Houghton-Rahrig L.D. Carbohydrate-restricted diet and exercise increase brain-derived neurotrophic factor and cognitive function: a randomized crossover trial. Cureus. 2019;11(9) doi: 10.7759/cureus.5604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Ferreira F.G., Reitz L.K., Valmorbida A., Papini Gabiatti M., Hansen F., Faria Di Pietro P., et al. Metabolically unhealthy and overweight phenotypes are associated with increased levels of inflammatory cytokines: a population-based study. Nutrition. 2022;96 doi: 10.1016/j.nut.2022.111590. [DOI] [PubMed] [Google Scholar]
  • 51.Bañuls C., Rovira-Llopis S., Lopez-Domenech S., Diaz-Morales N., Blas-Garcia A., Veses S., et al. Oxidative and endoplasmic reticulum stress is impaired in leukocytes from metabolically unhealthy vs healthy obese individuals. Int. J. Obes. (Lond). 2017;41(10):1556–1563. doi: 10.1038/ijo.2017.147. [DOI] [PubMed] [Google Scholar]
  • 52.Zhang L., Virgous C., Si H. Synergistic anti-inflammatory effects and mechanisms of combined phytochemicals. J Nutr. Biochem. 2019;69:19–30. doi: 10.1016/j.jnutbio.2019.03.009. [DOI] [PubMed] [Google Scholar]
  • 53.Zhu F., Du B., Xu B. Anti-inflammatory effects of phytochemicals from fruits, vegetables, and food legumes: a review. Crit. Rev. Food Sci. Nutr. 2018;58(8):1260–1270. doi: 10.1080/10408398.2016.1251390. [DOI] [PubMed] [Google Scholar]
  • 54.Kim C., Park K. Association between phytochemical index and inflammation in Korean adults. Antioxidants (Basel) 2022;11(2):348. doi: 10.3390/antiox11020348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Rigi S., Mousavi S.M., Shakeri F., Keshteli A.H., Benisi-Kohansal S., Saadatnia M., et al. Dietary phytochemical index in relation to risk of stroke: a case-control study. Nutr. Neurosci. 2022;25(11):2239–2246. doi: 10.1080/1028415X.2021.1954291. [DOI] [PubMed] [Google Scholar]
  • 56.Dehghani Firouzabadi F.D., Jayedi A., Asgari E., Farazi M., Noruzi Z., Djafarian K., et al. The association of dietary phytochemical index with metabolic syndrome in adults. Clin. Nutr. Res. 2021;10(2):161–171. doi: 10.7762/cnr.2021.10.2.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.B. Ahmadi, A.R. Ahmadi, M. Jafari, N. Morshedzadeh The association of dietary phytochemical index and nonalcoholic fatty liver disease. Food Sci. Nutr. 2023;11(7) doi: 10.1002/fsn3.3389. 4010–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Aghababayan S., Sheikhi Mobarakeh Z., Qorbani M., Abbasvandi F., Tiznobeyk Z., Aminianfar A., et al. Dietary phytochemical index and benign breast diseases: A case–control study. Nutr. Cancer. 2020;72(6):1067–1073. doi: 10.1080/01635581.2019.1658795. [DOI] [PubMed] [Google Scholar]
  • 59.Salehi-Abargouei A., Esmaillzadeh A., Azadbakht L., Keshteli A.H., Feizi A., Feinle-Bisset C., et al. Nutrient patterns and their relation to general and abdominal obesity in Iranian adults: findings from the SEPAHAN study. Eur. J Nutr. 2016;55(2):505–518. doi: 10.1007/s00394-015-0867-4. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data that support the findings of the present study are available from the corresponding author upon request.


Articles from Current Developments in Nutrition are provided here courtesy of American Society for Nutrition

RESOURCES